Okamato et al. (2000) detected GNAS pathogenic variants in five out of six (83%) intramuscular myxomas (60% p.R201H and 40% p.R201C) using PCR methodology together with single strand conformation polymorphism [10, 57]. This evidence concerns the gene GNAS and myxoma.